Crosslay Remedies Limited - Company Profile

Q: Who are the current directors of Crosslay Remedies Limited?

The current directors of Crosslay Remedies Limited are Vandana Ramesh Pakle, Gaurav Aggarwal, Yogesh Kumar Sareen, Mradul Kaushik, Anas Abdul Wajid, Arzoo Shingari.

It is a healthcare public limited company based in Sadar Bazar, Haryana, India, established in 2002.

2002 Sadar Bazar, Haryana, India Amalgamated

Last Updated: January 08, 2026

Access Report

About Crosslay Remedies Limited

Crosslay Remedies Limited, a amalgamated public limited company, was established on 08 January 2002 in Sadar Bazar, Haryana, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U24239HR2002PLC129635. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹157.00 Cr and a paid-up capital of ₹143.19 Cr.

Formerly known as Crosslay Remedies Private Limited. It upholds a compliant status. Employing 1,434 professional, Its leadership includes Vandana Ramesh Pakle (Director), Gaurav Aggarwal (Manager), Yogesh Kumar Sareen (Director). Past directors included Ajit Singh, Vandana Ramesh Pakle, Akhil Jain. It holds ₹350.00 Cr open charges and ₹983.96 Cr settled loans. Its latest AGM occurred on 29 July 2025, with the balance sheet filed on 31 March 2025. It is based at Max Hospital Gurugram, Block B Sushant Lok Phase 1, Sadar Bazar, Haryana, 122001.

Company Details

CIN/LLPIN
U24239HR2002PLC129635
Registration Number
129635
Incorporation Date
08 January 2002
Authorized Capital
₹157.00 Cr
Paid-Up Capital
₹143.19 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 157.00 Cr as on 08-01-2026
Paid Up Capital ₹ 143.19 Cr as on 08-01-2026
Company Age 24 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 350.00 Cr as on 08-01-2026
Satisfied Charges ₹ 983.96 Cr as on 08-01-2026

Comprehensive Company Insights

Explore comprehensive insights into Crosslay Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Crosslay Remedies Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vandana Ramesh Pakle	Director	29 Sep 2020	Current
Gaurav Aggarwal	Manager	01 Jun 2021	Current
Yogesh Kumar Sareen	Director	10 Jul 2015	Current
Mradul Kaushik	Director	18 Oct 2019	Current
Anas Abdul Wajid	Director	01 Jan 2019	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	23 Jan 2018	Past
Pramod Abcsdd	Additional Director	29 Sep 2020	Past
Pramod Abcsdd	Director	10 Jul 2015	Past
Pramod Abcsdd	Director	10 Nov 2009	Past
Pramod Abcsdd	Whole-Time Director	10 Jul 2015	Past
Pramod Abcsdd	Director	21 Nov 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Crosslay Remedies.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Crosslay Remedies?

Unlock access to Crosslay Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹3,500,000,000.00

Satisfied Charges

₹9,839,603,000.00

Charges Breakdown by Lending Institutions

Punjab National Bank : 671.94 Cr
Others : 180.00 Cr
Axis Bank Limited : 75.00 Cr
Canara Bank : 57.02 Cr

Latest Charge Details

Date	Lender	Amount	Status
20 Nov 2018	Axis Bank Limited	₹75.00 Cr	Satisfied
24 Feb 2016	Others	₹180.00 Cr	Satisfied
31 Mar 2015	Punjab National Bank	₹2.50 Cr	Satisfied
27 Sep 2014	Punjab National Bank	₹1.50 Cr	Satisfied
13 May 2014	Punjab National Bank	₹4.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Crosslay Remedies?

Unlock and access historical data on people associated with Crosslay Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Crosslay Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crosslay Remedies's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Crosslay Remedies

Recent Activity within the Organization

Annual General Meeting

The activity Crosslay Remedies Limited last Annual general meeting of members was held on 29 Jul 2025 as per latest MCA records. was completed.
29 Jul 2025
Director Appointment

Arzoo Shingari was appointed as a Company Secretary was appointed as a Company Secretary on 09 May 2025 & has been associated with this company since 9 months 18 days . was recorded as a recent event.
09 May 2025
Balance Sheet

The activity Crosslay Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
31 Mar 2025
Director Appointment

Gaurav Aggarwal was appointed as a Manager was appointed as a Manager on 01 Jun 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
01 Jun 2021
Charges

The activity A charge registered on 20 Nov 2018 via Charge ID 100221293 with Axis Bank Limited was fully satisfied on 09 Apr 2021. was completed.
09 Apr 2021
Charges

A charge registered on 24 Feb 2016 via Charge ID 10623417 with Others was fully satisfied on 09 Apr 2021. was recorded as a recent event.
09 Apr 2021

Explore recent activity and updates - View Recent Activity